0001193125-26-099169
SEC filingAN2 Therapeutics, Inc. entered into a Securities Purchase Agreement on March 8, 2026, involving the offer and sale of unregistered securities including Pre-Funded Warrants and underlying shares of Common Stock. Exhibits include the Form of Pre-Funded Warrant and the Securities Purchase Agreement.